Tucson-based High Throughput Genomics Inc. (HTG) has entered into a supply agreement with Roche NimbleGen Inc.
Under the deal, Madison, Wis.-based company will provide the local company with high-density DNA microarray slides for advanced gene expression analysis.
HTG will apply its proprietary technology, called the quantitative nuclease protection assay process, to the microarrays to enable researchers to quickly measure the gene expression levels in a variety of sample types, the companies said.
Roche NimbleGen is part of Swiss-based drug giant Roche.